Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Disease

Details for Australian Patent Application No. 2003264629 (hide)

International Classifications

Event Publications

18 December 2003 Complete Application Filed

8 January 2004 Application Open to Public Inspection

Published as AU-B-2003264629

5 April 2007 Application Accepted

Published as AU-B-2003264629

19 July 2007 Opposition Lodged

Abbott Bloresearch Centre has lodged an opposition against The Kennedy Institute of Rheumatology.

28 June 2012 Opposition Withdrawn

The opposition by Wyeth against The Kennedy Institute of Rheumatology has been withdrawn.

12 July 2012 Opposition Proceeding - Application Withdrawn

The opposition by Abbott Bloresearch Centre against The Kennedy Institute of Rheumatology has been withdrawn.

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(1). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.